| 注册
首页|期刊导航|中国药房|医联体药师团队协作建立慢性气道疾病患者长期用药安全评估管理模式的实践

医联体药师团队协作建立慢性气道疾病患者长期用药安全评估管理模式的实践

张楠 皮林 张新庆 夏文斌 张娜 闫阔 陆红柳 鲁秀玲 尤秀梅 李桃园 杨慧鹃 薛兵

中国药房2018,Vol.29Issue(11):1453-1457,5.
中国药房2018,Vol.29Issue(11):1453-1457,5.DOI:10.6039/j.issn.1001-0408.2018.11.04

医联体药师团队协作建立慢性气道疾病患者长期用药安全评估管理模式的实践

Practice of Management Mode of Long-term Medication Safety Assessment for Chronic Airway Disease Patients Established by Pharmacists Team of Medical Consortium

张楠 1皮林 1张新庆 1夏文斌 1张娜 1闫阔 1陆红柳 1鲁秀玲 1尤秀梅 1李桃园 1杨慧鹃 1薛兵1

作者信息

  • 1. 北京市垂杨柳医院药剂科,北京 100022
  • 折叠

摘要

Abstract

OBJECTIVE:To provide reference for pharmacists to participate in the management of chronic disease. METHODS:A total of 259 patients with chronic airway disease [included asthma and chronic obstructive pulmonary disease (COPD)] met the inclusion criteria were selected from our hospital and 5 community health care centers of medical consortium. These patients received medication safety assessment management,which was led by clinical pharmacists of our hospital with the participation of community pharmacists,including medication safety comprehensive evaluation and risk classification management, follow-up and medication guidance, integrated prescriptions checking, establishment of shared database. 1 years after the implementation,the effectiveness were evaluated by score the relatived indicators in related groups. RESULTS:After a year of the management mode practice,compared with before intervention,the patients'safety medication cognitive ability score in high-risk and low-risk group increased from(4.49±1.26)and(7.31±1.01)to(5.40±1.56)and(7.44±0.91);medication adherence score increased from(4.96±1.21)and(7.08±1.24)to(6.66±1.08)and(7.38±0.98);ACT score from asthma patients increased from (16.15±2.58)and(21.15±1.03)to(16.80±2.57)and(21.64±1.55);CAT score from COPD patients decreased from(25.51± 4.07) and (14.90 ± 3.95) to (24.20 ± 3.96) and (13.80 ± 4.08);the rate of irrational prescription effective identification and intervention by pharmacists increased from 3.6% and 1.4% to 9.4% and 7.6%,respectively. All the differences above were statistically significant (P<0.05). CONCLUSIONS:The participation of pharmacists in long-term medication safety assessment management for chronic airway disease patients can improve patients'safety medication cognitive ability,medication adherence, disease control and the pharmacists'ability of irrational drug use identification and intervention.

关键词

用药安全评估/慢性气道疾病患者/医联体/药师协作团队/管理模式/用药安全

Key words

Medication safety assessment/Chronic airway disease patients/Medical consortium/Pharmacists team/Management mode/Medication safety

分类

医药卫生

引用本文复制引用

张楠,皮林,张新庆,夏文斌,张娜,闫阔,陆红柳,鲁秀玲,尤秀梅,李桃园,杨慧鹃,薛兵..医联体药师团队协作建立慢性气道疾病患者长期用药安全评估管理模式的实践[J].中国药房,2018,29(11):1453-1457,5.

基金项目

北京市科技计划课题(No.Z171100001017256) (No.Z171100001017256)

北京市朝阳区科技计划基金(No.CYSF162303) (No.CYSF162303)

首都卫生发展科研专项资助项目(No.首发2011-7021-02) (No.首发2011-7021-02)

中国药房

OA北大核心CSTPCD

1001-0408

访问量0
|
下载量0
段落导航相关论文